| EEF1G |
EEF1G, EF1G, PRO1608: Elongation factor 1-gamma |
POLA2 |
POLA2: DNA polymerase subunit alpha B |
7.387 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
PRDX6 |
PRDX6, AOP2, KIAA0106: Peroxiredoxin-6 |
7.387 |
Evidence |
|
| UNG |
IPI00011069 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
7.387 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
NOL1 |
IPI00294891 |
7.387 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
7.387 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
7.387 |
Evidence |
|
| SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
7.387 |
Evidence |
|
| TOB1 |
TOB1, TOB, TROB1: Protein Tob1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
7.38 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
PEBP1 |
PEBP1, PBP, PEBP: Phosphatidylethanolamine-binding protein 1 |
7.38 |
Evidence |
|
| RPA1 |
RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
7.38 |
Evidence |
|
| GRIN2B |
GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
7.362 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
7.362 |
Evidence |
|
| GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
DGKD |
DGKD, KIAA0145: Diacylglycerol kinase delta |
7.362 |
Evidence |
|
| RELA |
RELA, NFKB3: Transcription factor p65 |
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
7.362 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
7.362 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
7.362 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
THBS3 |
THBS3, TSP3: Thrombospondin-3 precursor |
7.362 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
SMAD4 |
SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 |
7.362 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
7.362 |
Evidence |
|
| CHAT |
CHAT: Choline O-acetyltransferase |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
7.362 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
PHC2 |
PHC2, EDR2, PH2: Polyhomeotic-like protein 2 |
7.362 |
Evidence |
|
| PRKAR2A |
PRKAR2A, PKR2, PRKAR2: cAMP-dependent protein kinase type II-alpha regulatory su |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
7.362 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
SOS1 |
SOS1: Son of sevenless homolog 1 |
7.362 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
GAD2 |
GAD2, GAD65: Glutamate decarboxylase 2 |
7.362 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
7.362 |
Evidence |
|